Comparison

VEGFA Polyclonal Antibody

Item no. E-AB-19306-60
Manufacturer Elabscience
Amount 60 uL
Quantity options 120 uL 20 uL 200 uL 60 uL
Category
Type Antibody Polyclonal
Applications WB, IHC
Specific against Human (Homo sapiens)
Host Rabbit
Isotype IgG
Conjugate/Tag Unconjugated
Citations https://onlinelibrary.wiley.com/doi/abs/10.1111/aji.13589
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias Folliculostellate cell-derived growth factor, Glioma-derived endothelial cell mitogen, MGC70609, MVCD1, Vascular endothelial growth factor A, vascular endothelial growth factor A121, vascular endothelial growth factor A165, vascular endothelial growth factor, Vascular permeability factor, VEGF A, Vegf, VEGF-A, VEGF120, Vegfa, VEGFA, VPF
Similar products VEGF-A, VEGFA, Vascular endothelial growth factor A, Vascular permeability factor, Vegfa, VPF, MGC70609, MVCD1, VEGF A, VEGF120, Folliculostellate cell-derived growth factor, Glioma-derived endothelial cell mitogen, vascular endothelial growth factor A121, vascular endothelial growth factor A165, vascular endothelial growth factor, Vegf
Shipping Condition Cool pack
Hazard information Comply with cargo safety certificate
Available
Manufacturer - Category
Primary Antibodies
Manufacturer - Targets
VEGFA
Shipping Temperature
The product is shipped with ice pack, upon receipt, store it immediately at the temperature recommended.
Storage Conditions
Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Calculated Molecular Weight
27 kDa
Observed Molecular Weight
Refer to figures
Manufacturer - Research Areas
Cancer, Cardiovascular, Metabolism, Developmental Biology, Signal Transduction
Background
This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site.
Concentration
1.32 mg/mL
Buffer
PBS with 0.05% NaN3 and 40% Glycerol, pH7.4
Purification Method
Antigen affinity purification
Recommended Dilution
WB 1:1000-1:5000; IHC 1:25-1:100
Abbreviation
VEGFA
Clonality
Polyclonal
Immunogen
Synthetic peptide of human VEGFA
Category ID III
Polyclonal Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 60 uL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?